These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 28724122)

  • 1. Association Between Patient Age and Lymph Node Positivity in Thin Melanoma.
    Sinnamon AJ; Neuwirth MG; Yalamanchi P; Gimotty P; Elder DE; Xu X; Kelz RR; Roses RE; Chu EY; Ming ME; Fraker DL; Karakousis GC
    JAMA Dermatol; 2017 Sep; 153(9):866-873. PubMed ID: 28724122
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Should Sentinel Lymph Node Biopsy Be Performed for All T1b Melanomas in the New 8
    Egger ME; Stevenson M; Bhutiani N; Jordan AC; Scoggins CR; Philips P; Martin RC; McMasters KM
    J Am Coll Surg; 2019 Apr; 228(4):466-472. PubMed ID: 30660817
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinicopathologic Factors Predictive of Occult Lymph Node Involvement in Cutaneous Head and Neck Melanoma.
    Yalamanchi P; Brant JA; Chen J; Newman JG
    Otolaryngol Head Neck Surg; 2018 Mar; 158(3):489-496. PubMed ID: 29112483
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Predictors of sentinel lymph node positivity in thin melanoma using the National Cancer Database.
    Conic RRZ; Ko J; Damiani G; Funchain P; Knackstedt T; Vij A; Vidimos A; Gastman BR
    J Am Acad Dermatol; 2019 Feb; 80(2):441-447. PubMed ID: 30240775
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sentinel lymph node biopsy in patients with thin melanomas: Frequency and predictors of metastasis based on analysis of two large international cohorts.
    Isaksson K; Nielsen K; Mikiver R; Nieweg OE; Scolyer RA; Thompson JF; Ingvar C
    J Surg Oncol; 2018 Sep; 118(4):599-605. PubMed ID: 30196533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between age and likelihood of lymph node metastases in patients with intermediate thickness melanoma (1.01-4.00 mm): A National Cancer Database study.
    Hanna AN; Sinnamon AJ; Roses RE; Kelz RR; Elder DE; Xu X; Pockaj BA; Zager JS; Fraker DL; Karakousis GC
    J Am Acad Dermatol; 2019 Feb; 80(2):433-440. PubMed ID: 30165160
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sentinel lymph node biopsy in patients with thin primary cutaneous melanoma.
    Murali R; Haydu LE; Quinn MJ; Saw RP; Shannon K; Spillane AJ; Stretch JR; Thompson JF; Scolyer RA
    Ann Surg; 2012 Jan; 255(1):128-33. PubMed ID: 21975320
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lymphatic invasion identified by monoclonal antibody D2-40, younger age, and ulceration: predictors of sentinel lymph node involvement in primary cutaneous melanoma.
    Niakosari F; Kahn HJ; McCready D; Ghazarian D; Rotstein LE; Marks A; Kiss A; From L
    Arch Dermatol; 2008 Apr; 144(4):462-7. PubMed ID: 18427039
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vertical Growth Phase as a Prognostic Factor for Sentinel Lymph Node Positivity in Thin Melanomas: A Systematic Review and Meta-Analysis.
    Appleton SE; Fadel Z; Williams JS; Bezuhly M
    Plast Reconstr Surg; 2018 Jun; 141(6):1529-1540. PubMed ID: 29579032
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sentinel lymph node biopsy for the T1 (thin) melanoma: is it necessary?
    Nahabedian MY; Tufaro AP; Manson PN
    Ann Plast Surg; 2003 Jun; 50(6):601-6. PubMed ID: 12783009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinicopathologic predictors of sentinel lymph node metastasis in thin melanoma.
    Han D; Zager JS; Shyr Y; Chen H; Berry LD; Iyengar S; Djulbegovic M; Weber JL; Marzban SS; Sondak VK; Messina JL; Vetto JT; White RL; Pockaj B; Mozzillo N; Charney KJ; Avisar E; Krouse R; Kashani-Sabet M; Leong SP
    J Clin Oncol; 2013 Dec; 31(35):4387-93. PubMed ID: 24190111
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Early Melanoma Nodal Positivity and Biopsy Rates Before and After Implementation of the 7th Edition of the AJCC Cancer Staging Manual.
    Isom C; Wheless L; Hooks MA; Kauffmann RM
    JAMA Dermatol; 2019 May; 155(5):572-577. PubMed ID: 30840034
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Clark level risk stratifies patients with mitogenic thin melanomas for sentinel lymph node biopsy.
    Bartlett EK; Gimotty PA; Sinnamon AJ; Wachtel H; Roses RE; Schuchter L; Xu X; Elder DE; Ming M; Elenitsas R; Guerry D; Kelz RR; Czerniecki BJ; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2014 Feb; 21(2):643-9. PubMed ID: 24121883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Accuracy of lymphatic mapping and sentinel lymph node biopsy after previous wide local excision in patients with primary melanoma.
    Gannon CJ; Rousseau DL; Ross MI; Johnson MM; Lee JE; Mansfield PF; Cormier JN; Prieto VG; Gershenwald JE
    Cancer; 2006 Dec; 107(11):2647-52. PubMed ID: 17063497
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sentinel lymph node biopsy in elderly irish patients with malignant melanoma.
    Moran DE; Smith MJ; O'Sullivan MJ; Bannon H; Crotty TB; Collins CD; Skehan SJ; O'Higgins N; McDermott EW; Evoy D; Hill AD
    Ir Med J; 2007 Apr; 100(4):422-4. PubMed ID: 17566474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The effect of the AJCC 7th edition change in T1 melanoma substaging on national utilization and outcomes of sentinel lymph node biopsy for thin melanoma.
    Hieken TJ; Grotz TE; Comfere NI; Inselman JW; Habermann EB
    Melanoma Res; 2015 Apr; 25(2):157-63. PubMed ID: 25647736
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Practice Patterns and Prognostic Value of Sentinel Lymph Node Biopsy for Thick Melanoma: A National Cancer Database Study.
    Song Y; Azari FS; Metzger DA; Fraker DL; Karakousis GC
    Ann Surg Oncol; 2019 Dec; 26(13):4651-4662. PubMed ID: 31485823
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of sentinel lymph node biopsy in the management of invasive extramammary Paget's disease: Multi-center, retrospective study of 151 patients.
    Fujisawa Y; Yoshino K; Kiyohara Y; Kadono T; Murata Y; Uhara H; Hatta N; Uchi H; Matsushita S; Takenouchi T; Hayashi T; Fujimoto M; Ohara K
    J Dermatol Sci; 2015 Jul; 79(1):38-42. PubMed ID: 25944505
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sentinel lymph node biopsy for cutaneous melanoma: the Stanford experience, 1997-2004.
    Berk DR; Johnson DL; Uzieblo A; Kiernan M; Swetter SM
    Arch Dermatol; 2005 Aug; 141(8):1016-22. PubMed ID: 16103331
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Is it Necessary to Perform Sentinel Lymph Node Biopsy in Thin Melanoma? A Retrospective Single Center Analysis.
    Kocsis A; Karsko L; Kurgyis Z; Besenyi Z; Pavics L; Dosa-Racz E; Kis E; Baltas E; Ocsai H; Varga E; Bende B; Varga A; Mohos G; Korom I; Varga J; Kemeny L; Nemeth IB; Olah J
    Pathol Oncol Res; 2020 Jul; 26(3):1861-1868. PubMed ID: 31792874
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.